Back
Viking Therapeutics Stock Price Chart

While Jobs Disappear, Phones Are Picking Up The Slack
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
VKTX
Viking Therapeutics
Last Price:
$29.55
Seasonality Move:
2.26%
7 Day Trial
ALL ACCESS PASS
$
7

AI Is Changing Marketing Forever-Invest Before the Boom
Invest Now & Secure Your Stake in RAD Intel-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.94 | Sell |
20-day SMA: | 29.45 | Sell |
50-day SMA: | 33.83 | Sell |
200-day SMA: | 52.16 | Sell |
8-day EMA: | 28.18 | Sell |
20-day EMA: | 29.62 | Sell |
50-day EMA: | 34.57 | Sell |
200-day EMA: | 46.03 | Sell |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.86 | Sell |
Relative Strength Index (14 RSI): | 38.63 | Sell |
Chaikin Money Flow: | 5707205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.88 - 32.16) | Sell |
Bollinger Bands (100): | (31.52 - 60.06) | Sell |
Viking Therapeutics Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 26.52 while VKTX 8-day simple moving average is 27.94, which is a Sell signal.
-
The stock price of VKTX is 26.52 while Viking Therapeutics 20-day SMA is 29.45, which makes it a Sell.
-
Viking Therapeutics 50-day simple moving average is 33.83 while VKTX share price is 26.52, making it a Sell technically.
-
VKTX stock price is 26.52 and Viking Therapeutics 200-day simple moving average is 52.16, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
22
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a SellThe current Viking Therapeutics [VKTX] share price is $26.52. The Score for VKTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
3B
Price in USD:
26.52
Share Volume:
7.6M
Viking Therapeutics 52-Week Range
52-Week High:
89.10
52-Week Low:
24.41
Sell
22
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 26.52 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 26.52 while VKTX 8-day exponential moving average is 28.18, which is a Sell signal.
-
The stock price of VKTX is 26.52 while Viking Therapeutics 20-day EMA is 29.62, which makes it a Sell.
-
Viking Therapeutics 50-day exponential moving average is 34.57 while VKTX share price is 26.52, making it a Sell technically.
-
VKTX stock price is 26.52 and Viking Therapeutics 200-day simple moving average is 46.03, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.57 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is -1.86, suggesting Viking Therapeutics is a Sell
-
Viking Therapeutics Relative Strength Index (RSI) is 38.63, which suggest Viking Therapeutics is oversold
-
The Bollinger Bands (25) for Viking Therapeutics is (27.88 - 32.16), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (31.52 - 60.06), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.